Temokem 250mg Injection
Prescription Required
Product introduction
Temokem 250mg Injection is used in the treatment of a specific type of brain cancer. It is used to treat brain tumors if they return or get worse after standard treatment. It may be also used to treat other conditions, as determined by the doctor.
Temokem 250mg Injection is used in the treatment of many types of cancer
Temokem 250mg Injection is used in the treatment of many types of cancer
Uses of Temokem Injection
Benefits of Temokem Injection
In Brain tumor
Brain tumor is an abnormal mass or collection of cells that may be cancerous (malignant) or non-cancerous (benign). Temokem 250mg Injection kills or stops the growth of cancer cells and also prevents the multiplication of cancer cells. It is a potent and very toxic medicine and you should discuss the risks and benefits with your doctor. You should avoid drinking alcohol while having this treatment and drink plenty of water to stay hydrated.
Side effects of Temokem Injection
Most side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them
Common side effects of Temokem
- Memory loss
- Rash
- Headache
- Dizziness
- Convulsion
- Coordination disorder
- Insomnia (difficulty in sleeping)
- Vomiting
- Weakness
- Nausea
- Loss of appetite
- Hair loss
- Fatigue
- Fever
- Diarrhea
- Constipation
- Hemiparesis (weakness on one side of the body)
- Viral infection
How to use Temokem Injection
Your doctor or nurse will give you this medicine. Kindly do not self administer.
Safety advice
Alcohol
CONSULT YOUR DOCTOR
It is not known whether it is safe to consume alcohol with Temokem 250mg Injection. Please consult your doctor.
Pregnancy
CONSULT YOUR DOCTOR
Temokem 250mg Injection is unsafe to use during pregnancy as there is definite evidence of risk to the developing baby. However, the doctor may rarely prescribe it in some life-threatening situations if the benefits are more than the potential risks. Please consult your doctor.
Breast feeding
UNSAFE
Temokem 250mg Injection is unsafe to use during breastfeeding. Data suggests that the drug may cause toxicity to the baby.
Driving
UNSAFE
Temokem 250mg Injection may decrease alertness, affect your vision or make you feel sleepy and dizzy. Do not drive if these symptoms occur.
Kidney
SAFE IF PRESCRIBED
Temokem 250mg Injection is probably safe to use in patients with kidney disease. Limited data available suggests that dose adjustment of Temokem 250mg Injection may not be needed in these patients. Please consult your doctor.
Cautious use is advised in patients with severe kidney disease while they are taking Temokem 250mg Injection.
Cautious use is advised in patients with severe kidney disease while they are taking Temokem 250mg Injection.
Liver
CAUTION
Temokem 250mg Injection should be used with caution in patients with severe liver disease. Dose adjustment of Temokem 250mg Injection may be needed. Please consult your doctor.
Limited information is available on the use of Temokem 250mg Injection in these patients. No dose adjustment is recommended in patients with mild to moderate liver disease.
Limited information is available on the use of Temokem 250mg Injection in these patients. No dose adjustment is recommended in patients with mild to moderate liver disease.
All substitutes
For informational purposes only. Consult a doctor before taking any medicines.
No substitutes found for this medicine
Quick tips
- Temokem 250mg Injection is given as an injection into the vein under the supervision of a doctor only.
- Do not skip any dose and complete the course as suggested by your doctor.
- Use an effective method of birth control to avoid pregnancy while taking this medication.
- It increases your risk of bleeding. Be careful while shaving, cutting fingernails or toenails, or using sharp objects.
- Your doctor may get regular blood tests done to monitor your blood cell count and liver function.
- Inform your doctor if you experience severe skin rash, fever, chills, headache and shortness of breath during the treatment.
Fact Box
Chemical Class
Dacarbazine Derivative
Habit Forming
No
Therapeutic Class
ANTI NEOPLASTICS
Action Class
Alkylating agent
Patient concerns
Want to share the information?
Disclaimer:
Tata 1mg's sole intention is to ensure that its consumers get information that is expert-reviewed, accurate and trustworthy. However, the information contained herein should NOT be used as a substitute for the advice of a qualified physician. The information provided here is for informational purposes only. This may not cover everything about particular health conditions, lab tests, medicines, all possible side effects, drug interactions, warnings, alerts, etc. Please consult your doctor and discuss all your queries related to any disease or medicine. We intend to support, not replace, the doctor-patient relationship.References
- Chabner BA, Bertino J, Cleary J, et al. Cytotoxic Agents. In: Brunton LL, Chabner BA, Knollmann BC, editors. Goodman & Gilman’s: The Pharmacological Basis of Therapeutics. 12th ed. New York, New York: McGraw-Hill Medical; 2011. p. 1687.
- Briggs GG, Freeman RK, editors. A Reference Guide to Fetal and Neonatal Risk: Drugs in Pregnancy and Lactation. 10th ed. Philadelphia, PA: Wolters Kluwer Health; 2015. pp. 1324-25.
- Temozolomide. Whitehouse Station, New Jersey: Merck & Co., Inc.; 1999 [revised Sep. 2015]. [Accecssed 25 Jan. 2019] (online) Available from:
- Drugs and Lactation Database (LactMed) [Internet]. Bethesda (MD): National Library of Medicine (US); 2006. Temozolamide. [Updated 2018 Dec 3]. [Accessed 18 Feb. 2020] (online) Available from:
- Central Drugs Standard Control Organisation (CDSCO). [Accessed 27 Mar. 2019] (online) Available from:
Marketer details
Name: Alkem Laboratories Ltd
Address: Alkem Laboratories Limited, Devashish Building, Alkem House, Senapati Bapat Road, Lower Parel, Mumbai - 400 013.
Country of origin: India
Lab tests offered by us
Related/Popular tests
MRP
₹19375
Inclusive of all taxes
5.0 injections in 1 packet
SOLD OUT
Notify me